ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio Net Income (Quarterly) : -10.18M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.18M |
| March 31, 2026 | -10.62M |
| December 31, 2025 | -6.908M |
| September 30, 2025 | -24.78M |
| June 30, 2025 | -7.585M |
| March 31, 2025 | -6.077M |
| December 31, 2024 | -4.812M |
| September 30, 2024 | -3.183M |
| June 30, 2024 | -13.73M |
| March 31, 2024 | -16.15M |
| December 31, 2023 | -19.49M |
| September 30, 2023 | -17.34M |
| June 30, 2023 | -17.12M |
| March 31, 2023 | -14.22M |
| Date | Value |
|---|---|
| December 31, 2022 | -14.10M |
| September 30, 2022 | -17.34M |
| June 30, 2022 | -20.49M |
| March 31, 2022 | -16.84M |
| December 31, 2021 | 2.797M |
| September 30, 2021 | -14.52M |
| June 30, 2021 | -12.68M |
| March 31, 2021 | -9.716M |
| December 31, 2020 | -26.05M |
| September 30, 2020 | -6.222M |
| June 30, 2020 | -5.038M |
| March 31, 2020 | -6.945M |
| December 31, 2019 | -5.108M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 10.18M |
| EPS Diluted (Quarterly) | -0.6298 |
| Enterprise Value | -84.70M |
| Earnings Yield | -124.8% |
| Normalized Earnings Yield | -124.85 |